Latest News

global health | Image credit: Tex vector - stock.adobe.com
Challenges and Guidance in Biosimilar Assessment: An ISPOR Report on HTA Agency Approaches

May 14th 2024

The ISPOR report highlights the urgent need for clear guidance on when and how to conduct health technology assessments (HTAs) for biosimilars, emphasizing the challenges faced by HTA agencies and the evolving role of HTAs in evaluating biosimilar value.

vials AI generated | Image credit: pixardi - stock.adobe.com
Partnering for Biosimilar Security: India's Role in US Health Care Savings, Supply Chain Stability

May 9th 2024

FDA building | Image credit: JHVEPhoto - stock.adobe.com
BioRationality—FDA’s Guidance on Promotional Labeling

May 6th 2024

cancer treatment | Image credit: Monkey Business - stock.adobe.com
Cencora Analysis Shows Differences in Payer Coverage Between G-CSF Biosimilars

May 2nd 2024

Biosimilars Policy Roundup: April 2024
Biosimilars Policy Roundup: April 2024

May 1st 2024

More News

© 2024 MJH Life Sciences

All rights reserved.